RE:RE:RE:RE:trading?Traders selling news, did happen to a degree yesterday. As SF just said there has to be some clarification on the business side of the equation for the stock to move. I think over the years there has been a GREAT DEAL of investor fatigue as far as RVX is concerned. Management has been consistently poor at communicating and controlling their message and as such any adversity has been met with considerably investor pain. I know a number of investors who have been burned by this stock and as such are highly suspicious of managements abilities, regardless of scientific achievement. Of these investors I know that many who are still following the story would not consider taking a new position in this stock until such time that it is covered by analysts who are affiliated with respected brokerages and who will give an opinion as to RVX's viability both from a scientific and a business perspective. I remember talking to Sarah when we were still waiting for SUSTAIN results and she told me at that time that there were a number of such analysts who were awaiting the full data set from SUSTAIN and then they would be initiating coverage. NEVER HAPPENED =big management failure.
I personally believe that the science is there but as we sit I see four possibilities 1) A CVR or other money deal where the stock will move accordingly. 2) An increase in the RVX LoC (likely would be involving Ken Dart if anybody), if on favourable terms the stock should move significantly as there could be relatively little dilution and business clarification would be achieved. 3) An equity financing where dilution could be significant and the stock may move up due to clarification but may not move much depending on dilution. 4) Management fails to find a way forward and RVX goes to zero despite scientific achievement. I think the possibility of number 4 coupled with a complete lack of previous biotech business achievement or track record from management keeps a number of investors on the sidelines.
JMO